| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/2002 | EP1196446A1 Protamine-free insoluble acylated insulin compositions |
| 04/17/2002 | EP1196444A1 Peptides that lower blood glucose levels |
| 04/17/2002 | EP1196443A2 Erythropoietin conjugates with polyethylenglycol |
| 04/17/2002 | EP1196442A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196441A1 Keratinocyte growth factor-2 |
| 04/17/2002 | EP1196440A2 Therapeutic peptides derived from subsequences of bpi |
| 04/17/2002 | EP1196439A2 Compounds exhibiting an antibiotic activity |
| 04/17/2002 | EP1196438A1 A ligand of the protein "beacon" |
| 04/17/2002 | EP1196437A1 Fima PILUS-BASED VACCINES |
| 04/17/2002 | EP1196436A2 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 04/17/2002 | EP1196434A2 Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes |
| 04/17/2002 | EP1196432A2 FVIIa ANTAGONISTS |
| 04/17/2002 | EP1196431A1 A substantially crystalline form of melagatran |
| 04/17/2002 | EP1196430A2 Purification and stabilization of peptide and proteins in pharmaceutical agents |
| 04/17/2002 | EP1196429A2 Process for the deprotection of protected thiols |
| 04/17/2002 | EP1196197A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 04/17/2002 | EP1196191A1 Death domain containing receptor 5 |
| 04/17/2002 | EP1196188A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196186A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 04/17/2002 | EP1196184A1 Compositions and methods for treatment of sexual dysfunction |
| 04/17/2002 | EP1196128A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 04/17/2002 | EP1196041A2 Methods and means for producing improved dairy products |
| 04/17/2002 | EP1196030A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 04/17/2002 | EP1196027A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 04/17/2002 | EP1196026A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 04/17/2002 | EP1007561B1 Novel conjugates of opioids and endogenous carriers |
| 04/17/2002 | EP0935609B1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
| 04/17/2002 | EP0886652B1 Pulmonary surfactant peptide solubilization process |
| 04/17/2002 | EP0876152B1 Novel administration of thrombopoietin |
| 04/17/2002 | EP0852627A4 Cell death protein |
| 04/17/2002 | EP0831902A4 Muscle trophic factor |
| 04/17/2002 | EP0826047B1 Recombinant baculovirus insecticides |
| 04/17/2002 | EP0793506B1 Cellular and serum protein anchors and conjugates |
| 04/17/2002 | EP0662827B1 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 04/17/2002 | EP0623146B1 Compositions and methods for inhibiting beta-protein function |
| 04/17/2002 | EP0500785B1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 04/17/2002 | EP0359783B2 Treatment of autoimmune diseases by oral administration of autoantigens |
| 04/17/2002 | CN1345375A Streptococcus pneumoniae antigens |
| 04/17/2002 | CN1345374A HER-2/neu fusion proteins |
| 04/17/2002 | CN1345371A Process for producing HMG-CoA reductase inhibitor |
| 04/17/2002 | CN1345370A Compartmentalization of recombinant polypeptides in host cells |
| 04/17/2002 | CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 04/17/2002 | CN1345335A Melanocortin receptor ligands |
| 04/17/2002 | CN1345330A Pigment protein from coral tissue |
| 04/17/2002 | CN1345329A Tumor mecrosis factor receptors 6 alpha and beta |
| 04/17/2002 | CN1345301A Improved compounds for protein binding |
| 04/17/2002 | CN1345251A Methods and compositions for healing and repair of articular cartilage |
| 04/17/2002 | CN1345247A Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas |
| 04/17/2002 | CN1345246A Compositions and method for prevention or treatment of cancer and bone loss associated with cancer |
| 04/17/2002 | CN1345245A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 04/17/2002 | CN1344745A Martentoxin as one great-conductance calcium-activating potassium channel blocker and its prepn and use |
| 04/17/2002 | CN1344744A Human testicular development specific protein-27 gene encoding protein |
| 04/17/2002 | CN1344743A Human testicular development specific protein-26 gene encoding protein |
| 04/17/2002 | CN1344742A Human testicualr development specific protein-24 gene encoding protein |
| 04/17/2002 | CN1344741A Human testicular development specific protein-21 gene encoding protein |
| 04/17/2002 | CN1344740A Human testicular development specific protein-20 gene encoding protein |
| 04/17/2002 | CN1344739A Human testicular development specific protein-20B gene encoding protein |
| 04/17/2002 | CN1344738A Human testicular development specific protein-18 gene encoding protein |
| 04/17/2002 | CN1344737A Human testicular development specific protein-5 gene encoding protein |
| 04/17/2002 | CN1344736A 9-0-acetyl esterase gene encoding protein |
| 04/17/2002 | CN1344735A Human testicular development specific protein-19 gene encoding protein |
| 04/17/2002 | CN1344734A New polypeptide huamn autosomal fragile mental retardation syndrome related protein 10.45 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344733A New polypeptide human transcription factor LCR-F15.95 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344732A New polypeptide human zinc finger protein 10.12 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344731A New polypeptide human excitatory amino acid translocator 12.65 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344730A New polypeptide human ribosomal protein S9.9 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344729A New polypeptide human visinin-like protein 13.75 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344728A New polypeptide human macro protein 0193-20.79 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344727A Multifunctional mycoprotein product for plant and its prepn |
| 04/17/2002 | CN1344726A New polypeptie ribosomal protein S15.84 and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344725A New polypeptide protein 86.90 with rich proline and polynucleotides encoding this polypeptide |
| 04/17/2002 | CN1344724A New polypeptide mitochondrion sorting protein 1-39.71 and polynucleotides encoding this polypeptide |
| 04/16/2002 | US6372967 Plants with modified stamen cells |
| 04/16/2002 | US6372962 Useful for producing plants having virus resistance characteristics |
| 04/16/2002 | US6372961 For enhancing seed germination and seedling growth, for manipulating oxygen concentration in the plant cell and organelles contributing to the overall growth and metabolism of the plant |
| 04/16/2002 | US6372960 Barstar gene |
| 04/16/2002 | US6372959 Expression vector of a mud loach growth hormone gene |
| 04/16/2002 | US6372958 Transgenic mouse with endogenous endoglin gene disruption |
| 04/16/2002 | US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use |
| 04/16/2002 | US6372956 Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor |
| 04/16/2002 | US6372955 Methods for Producing B cells and antibodies from H2-O modified transgenic mice |
| 04/16/2002 | US6372900 Horse endothelin-B receptor gene and gene products |
| 04/16/2002 | US6372899 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 04/16/2002 | US6372897 Mimotopic polypeptides of toxoplasma gondii and applications |
| 04/16/2002 | US6372896 Kits for detecting fOHY030 |
| 04/16/2002 | US6372892 Interleukin—1 Hy2 materials and methods |
| 04/16/2002 | US6372891 Human G-protein receptor HPRAJ70 |
| 04/16/2002 | US6372890 Water-soluble polypeptides |
| 04/16/2002 | US6372889 Soluble protein ZTMPO-1 |
| 04/16/2002 | US6372888 Useful for combating fungal diseases in agricultural, pharmaceutical or preservative applications |
| 04/16/2002 | US6372887 Used to protect an animal from flea infestation |
| 04/16/2002 | US6372886 Useful for expression of the kringle domains and to the production of antibodies to human lipoprotein |
| 04/16/2002 | US6372884 Comparing amino acid sequences of complementarity-determining regions of an anti-receptor antibody that mimics or blocks a biologically active protein; identifying amino acid sequence in complementarity-determining region; synthesizing |
| 04/16/2002 | US6372721 Injecting vector comprising nucleic acid coding protein into or near peripheral nervous system; gene expression; biosynthesis; gene therapy for nervous system or brain disorders |
| 04/16/2002 | US6372720 Liposome fusion and delivery vehicle |
| 04/16/2002 | US6372711 Receptor binding assay using polypeptide have contiguous sequence of extracellular domain or polypeptide mutein genetically engineered by insertion, deletion, or replacement |
| 04/16/2002 | US6372510 Method for removing unconventional transmissible agents from a protein solution |
| 04/16/2002 | US6372500 For transfection of epithelial tissue with the cassettes in therapy of cystic fibrosis, emphysema, cancers of epithelial origin arising in the lung or other organs |
| 04/16/2002 | US6372497 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |